Last reviewed · How we verify
GnRH analog and recombinant human FSH
GnRH analog and recombinant human FSH is a Small molecule drug developed by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. It is currently in Phase 1 development. Also known as: decapeptyl, Gonal-F.
At a glance
| Generic name | GnRH analog and recombinant human FSH |
|---|---|
| Also known as | decapeptyl, Gonal-F |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Aurora Test for ART Donor Patients (AURORA-Donor)
- Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol (NA)
- Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders (PHASE3)
- Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve (NA)
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI (PHASE4)
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes. (PHASE4)
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI (PHASE4)
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GnRH analog and recombinant human FSH CI brief — competitive landscape report
- GnRH analog and recombinant human FSH updates RSS · CI watch RSS
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico portfolio CI
Frequently asked questions about GnRH analog and recombinant human FSH
What is GnRH analog and recombinant human FSH?
GnRH analog and recombinant human FSH is a Small molecule drug developed by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.
Who makes GnRH analog and recombinant human FSH?
GnRH analog and recombinant human FSH is developed by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (see full Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico pipeline at /company/fondazione-irccs-ca-granda-ospedale-maggiore-policlinico).
Is GnRH analog and recombinant human FSH also known as anything else?
GnRH analog and recombinant human FSH is also known as decapeptyl, Gonal-F.
What development phase is GnRH analog and recombinant human FSH in?
GnRH analog and recombinant human FSH is in Phase 1.
Related
- Manufacturer: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico — full pipeline
- Also known as: decapeptyl, Gonal-F
- Compare: GnRH analog and recombinant human FSH vs similar drugs
- Pricing: GnRH analog and recombinant human FSH cost, discount & access